Inventor · disambiguated record
Hitoshi Katada
Also filed as: KATADA HITOSHI
17 granted patents·14 pending applications·203 citations·filing 2012–2024
94Inventor score
Top patents by PatentIndex Score
31 records- 0197US11142587B2Method for producing polypeptide hetero-oligomerCHUGAI PHARMACEUTICAL CO LTD·Filed 2016·Granted Oct 12, 2021·13 cites·14 claims
- 0296US11718678B2Method for altering plasma retention and immunogenicity of antigen-binding moleculeCHUGAI PHARMACEUTICAL CO LTD·Filed 2020·Granted Aug 8, 2023·7 cites·16 claims
- 0396US11454633B2Anti-myostatin antibodies, polypeptides containing variant Fc regions, and methods of useCHUGAI PHARMACEUTICAL CO LTD·Filed 2020·Granted Sep 27, 2022·4 cites·19 claims
- 0496US10738111B2Anti-myostatin antibodies, polypeptides containing variant Fc regions, and methods of useCHUGAI PHARMACEUTICAL CO LTD·Filed 2018·Granted Aug 11, 2020·17 cites·25 claims
- 0596US10000560B2Anti-myostatin antibodies, polypeptides containing variant Fc regions, and methods of useCHUGAI PHARMACEUTICAL CO LTD·Filed 2015·Granted Jun 19, 2018·26 cites·43 claims
- 0694US11267868B2Fc region variantCHUGAI PHARMACEUTICAL CO LTD·Filed 2014·Granted Mar 8, 2022·13 cites·3 claims
- 0794US11124576B2Method for producing polypeptide heteromultimerCHUGAI PHARMACEUTICAL CO LTD·Filed 2014·Granted Sep 21, 2021·20 cites·38 claims
- 0894US10919953B2FcgammaRIIB-specific Fc region variantCHUGAI PHARMACEUTICAL CO LTD·Filed 2013·Granted Feb 16, 2021·24 cites·8 claims
- 0994US10618965B2Method for altering plasma retention and immunogenicity of antigen-binding moleculeIGAWA TOMOYUKI·Filed 2012·Granted Apr 14, 2020·32 cites·33 claims
- 1093US9890218B2Heterodimerized polypeptideMIMOTO FUTA·Filed 2012·Granted Feb 13, 2018·32 cites·39 claims
- 1191US10766960B2Heterodimerized polypeptideCHUGAI PHARMACEUTICAL CO LTD·Filed 2013·Granted Sep 8, 2020·13 cites·17 claims
- 1287US2025076311A1Anti-myostatin antibodies, polypeptides containing variant fc regions, and methods of useCHUGAI PHARMACEUTICAL CO LTD·Filed 2024·Application pending·0 cites
- 1379US12371511B2Heterodimerized polypeptideCHUGAI PHARMACEUTICAL CO LTD·Filed 2018·Granted Jul 29, 2025·1 cites·29 claims
- 1478US12054544B2Compositions comprising antigen-binding moleculesCHUGAI PHARMACEUTICAL CO LTD·Filed 2018·Granted Aug 6, 2024·1 cites·21 claims
- 1578US2023174655A1Fc-gamma-RIIb-SPECIFIC Fc ANTIBODYCHUGAI PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 1678US2024417464A1Compositions comprising antigen-binding moleculesCHUGAI PHARMACEUTICAL CO LTD·Filed 2024·Application pending·0 cites
- 1777US12415857B2Anti-CTLA-4 antibody and use thereofCHUGAI PHARMACEUTICAL CO LTD·Filed 2023·Granted Sep 16, 2025·0 cites·21 claims
- 1872US12359001B2Method for producing polypeptide hetero-oligomerCHUGAI PHARMACEUTICAL CO LTD·Filed 2021·Granted Jul 15, 2025·0 cites·24 claims
- 1971US12448451B2Anti-CTLA-4 antibody and use thereofCHUGAI PHARMACEUTICAL CO LTD·Filed 2022·Granted Oct 21, 2025·0 cites·20 claims
- 2068US2023140797A1ANTIGEN-BINDING MOLECULE FOR PROMOTING DISAPPEARANCE OF ANTIGEN VIA Fc GAMMA RIIBCHUGAI PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 2167US12169205B2Anti-myostatin antibodies, polypeptides containing variant fc regions, and methods of useCHUGAI PHARMACEUTICAL CO LTD·Filed 2018·Granted Dec 17, 2024·0 cites·5 claims
- 2265US2022411483A1Fc REGION VARIANTCHUGAI PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 2363US2024043515A1Heterodimer fc polypeptideCHUGAI PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 2462US2024270806A1Protease-activated cytokineCHUGAI PHARMACEUTICAL CO LTD·Filed 2024·Application pending·0 cites
- 2562US2023058982A1Anti-ctla-4 antibody and use thereofCHUGAI PHARMACEUTICAL CO LTD·Filed 2019·Application pending·0 cites
- 2661US2021261648A1FCgammaRIIB-SPECIFIC FC REGION VARIANTCHUGAI PHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
- 2761US2023257470A1Method for altering plasma retention and immunogenicity of antigen-binding moleculeCHUGAI PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 2859US2023416371A1Heterodimer fc polypeptideCHUGAI PHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
- 2956US2014093496A1Fc-gamma-RIIb-SPECIFIC Fc ANTIBODYMIMOTO FUTA·Filed 2012·Application pending·0 cites
- 3053US2022315909A1Protease substrate, and polypeptide including protease cleavage sequenceCHUGAI PHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
- 3149US2016046693A1Antigen-Binding Molecule for Promoting Disappearance of Antigen via Fc gamma RIIBCHUGAI PHARMACEUTICAL CO LTD·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Hitoshi Katada files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →